Efficacy of TAV-in-TAV using SAPIEN3 Ultra RESILIA for supra-skirtal-leakage with intravascular hemolysis
Cardiovascular Intervention and Therapeutics · 2024
DOI: 10.1007/s12928-024-01007-3 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cardiovascular Intervention and Therapeutics, 2024. Verfasst von Ryo Otake und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sapporo Cardiovascular Clinic, 8-1, Kita-49 Higashi-16, Higashiku, Sapporo, 007-0849, Japan. a11f130073@gmail.com. Hauptthemen laut MEDLINE: Hemolysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, Sapporo Cardiovascular Clinic, 8-1, Kita-49 Higashi-16, Higashiku, Sapporo, 007-0849, Japan. a11f130073@gmail.com.
- Department of Cardiology, Sapporo Cardiovascular Clinic, 8-1, Kita-49 Higashi-16, Higashiku, Sapporo, 007-0849, Japan.
Zitieren
APA
Otake, R., Hachinohe, D., Horita, R., Armando Diaz, J., Shitan, H., & Fujita, T. (2024). Efficacy of TAV-in-TAV using SAPIEN3 Ultra RESILIA for supra-skirtal-leakage with intravascular hemolysis. Cardiovascular Intervention and Therapeutics. https://doi.org/10.1007/s12928-024-01007-3
Vancouver
Otake R, Hachinohe D, Horita R, Armando Diaz J, Shitan H, Fujita T. Efficacy of TAV-in-TAV using SAPIEN3 Ultra RESILIA for supra-skirtal-leakage with intravascular hemolysis. Cardiovascular Intervention and Therapeutics. 2024. doi:10.1007/s12928-024-01007-3
BibTeX
@article{Otake2024,
author = {Otake, Ryo and Hachinohe, Daisuke and Horita, Ryo and Armando Diaz, Juan and Shitan, Hidemasa and Fujita, Tsutomu},
title = {Efficacy of TAV-in-TAV using SAPIEN3 Ultra RESILIA for supra-skirtal-leakage with intravascular hemolysis},
journal = {Cardiovascular Intervention and Therapeutics},
year = {2024},
doi = {10.1007/s12928-024-01007-3}
}
EUVIMED